Globus Medical (MEX:GMED) Cyclically Adjusted Revenue per Share: MXN (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:GMED Globus Medical Inc MEX:GMED
90 GF Score
Price MXN1,390.45
GF Value MXN1,755.67
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Globus Medical Cyclically Adjusted Revenue per Share?

Globus Medical MEX:GMED 90 Cyclically Adjusted Revenue per Share is MXN as of Jun. 2026. GuruFocus rates MEX:GMED with a GF Score™ of 90/100 and a GF Value™ of MXN1,755.67 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Globus Medical's adjusted revenue per share for the three months ended in Jun. 2026 was MXN99.979. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN for the trailing ten years ended in Jun. 2026.

During the past 12 months, Globus Medical's average Cyclically Adjusted Revenue Growth Rate was 17.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 14.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Globus Medical was 14.70% per year. The lowest was 12.90% per year. And the median was 13.60% per year.

As of today (2026-09-20), Globus Medical's current stock price is MXN1390.45. Globus Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN. Globus Medical's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Globus Medical was 12.34. The lowest was 4.64. And the median was 7.35.


Globus Medical  (MEX:GMED) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Globus Medical was 12.34. The lowest was 4.64. And the median was 7.35.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Globus Medical Cyclically Adjusted Revenue per Share Related Terms


Globus Medical Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Globus Medical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical Cyclically Adjusted Revenue per Share Chart

Globus Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Globus Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MEX:GMED vs GKOS, BIO, PODD: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Globus Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Globus Medical Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Globus Medical's Cyclically Adjusted PS Ratio falls into.


MEX:GMED
90GF Score
Globus Medical Inc MEX:GMED
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Globus Medical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Globus Medical's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=99.979/333.9520*333.9520
=99.979

Current CPI (Jun. 2026) = 333.9520.

Globus Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 26.368 241.428 36.473
201612 31.164 241.432 43.106
201703 32.561 243.801 44.601
201706 28.899 244.955 39.399
201709 27.655 246.819 37.418
201712 33.800 246.524 45.787
201803 32.507 249.554 43.501
201806 33.144 251.989 43.925
201809 31.554 252.439 41.743
201812 38.220 251.233 50.804
201903 34.656 254.202 45.529
201906 36.630 256.143 47.757
201909 37.343 256.759 48.570
201912 39.591 256.974 51.451
202003 37.399 258.115 48.387
202006 35.627 257.797 46.151
202009 47.537 260.280 60.992
202012 47.318 260.474 60.666
202103 45.187 264.877 56.971
202106 48.573 271.696 59.703
202109 44.067 274.310 53.648
202112 49.810 278.802 59.663
202203 45.423 287.504 52.761
202206 51.384 296.311 57.911
202209 50.731 296.808 57.080
202212 52.877 296.797 59.496
202303 50.512 301.836 55.887
202306 50.710 305.109 55.504
202309 56.809 307.789 61.638
202312 77.892 306.746 84.800
202403 76.161 312.332 81.433
202406 79.264 314.175 84.254
202409 85.791 315.301 90.866
202412 94.543 315.605 100.039
202503 87.338 319.799 91.203
202506 106.620 322.561 110.385
202509 105.833 324.800 108.815
202512 110.750 324.054 114.133
202603 96.555 330.213 97.648
202606 99.979 333.952 99.979

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN mean?
Globus Medical (MEX:GMED) has a Cyclically Adjusted Revenue per Share of MXN as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Globus Medical and its competitors.
Is Globus Medical's Cyclically Adjusted Revenue per Share too high?
Globus Medical's current Cyclically Adjusted Revenue per Share is MXN. Overall, Globus Medical has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Cyclically Adjusted Revenue per Share compare to GKOS and BIO?
Globus Medical's Cyclically Adjusted Revenue per Share of MXN can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Globus Medical and its competitors. Globus Medical's current Cyclically Adjusted Revenue per Share is MXN. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,755.67, compared to a current price of MXN1,390.45 — trading 20.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN. Globus Medical's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current Cyclically Adjusted Revenue per Share is MXN as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globus Medical (MEX:GMED) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of MXN1,390.45 is trading 20.8% below its estimated GF Value™ of MXN1,755.67. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for MEX:GMED:

  • Cyclically Adjusted Revenue per Share: MXN
  • GF Value™: MXN1,755.67 vs. price of MXN1,390.45 (20.8% below fair value)
  • GF Score™: 90/100 with 4 warning signs

No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Globus Medical Business Description

Other Exchanges GMED:USAGM0N:Germany
Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
90GF Score

Get the complete analysis for MEX:GMED

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,390.45
Price
MXN1,755.67
GF Value